Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Smoldering Multiple Myeloma 1Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1Kidney Neoplasms 1

Interventions

Carboplatin 2tanespimycin 1sargramostim 1alethine 1Peripheral Blood Stem Cell Transplantation 1Interleukin-12 Subunit p35 1Interferon-alpha 1Imatinib Mesylate 1Ifosfamide 1Docetaxel 1Decitabine 1Cyclophosphamide 1Celecoxib 1Amifostine 1AH 111585 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Monoclonal Gammopathy of Undetermined Significance × AH 111585 × Clear all
NCT01571726 2019-12-16

Imaging Studies and the Development of Multiple Myeloma

National Institutes of Health Clinical Center (CC)

Phase 2 Withdrawn
Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡